Kind of OT because this trial seems to be about
diabetes/obesity but as we know, Akkermansia muciniphila is often reduced in people with IBD (according to ubiome I had none) so would be interesting to see what taking it would produce although I read studies this year that said it made mice flare worse in the presence of certain other bacteria.
www.gutmicrobiotaforhealth.com/en/new-insights-akkermansia-muciniphila-improves-metabolic-health-leading-first-human-safety-trial/News that they have produced a version that can be administered to humans, I wonder if and when the public could get their hands on it. If it helps against obesity they would keep the price sky high I imagine.